Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Feb
3
2023
Bankruptcy Court Finds Cannabis Employee Not Entitled to Chapter 13 Protection Mintz
Feb
3
2023
FDA Announces Qualified Health Claim for Cocoa Flavanols in High Flavanol Cocoa Powder and Reduced Risk of Cardiovascular Disease Keller and Heckman LLP
Feb
3
2023
Revamping of Cosmetics Regulation and Safety Squire Patton Boggs (US) LLP
Feb
2
2023
Food and Chemicals Unpacked: Extended Producer Responsibility: EPR You Ready? [PODCAST] Keller and Heckman LLP
Feb
2
2023
340B Covered Entities May See Access Changes to Contrast Media, Radiopharmaceuticals and Other Products McDermott Will & Emery
Feb
2
2023
EU Tightens Checks on Vanilla Extract from US Keller and Heckman LLP
Feb
1
2023
Not so FAST – AB 257 on Hold Pending Voter Referendum in 2024 Jackson Lewis P.C.
Feb
1
2023
If at First You Don’t Succeed: Updated Medical Cannabis Bill Filed in South Carolina Bradley Arant Boult Cummings LLP
Feb
1
2023
Unpacking Averages: Using NLP to Assess FDA’s Compliance with Notice and Comment in Guidance Development Epstein Becker & Green, P.C.
Feb
1
2023
FDA Announces Proposed Redesign to Create Human Foods Program Keller and Heckman LLP
Jan
31
2023
Bankruptcy Court Doors Swing Open For Cannabis Companies, But Just Slightly Squire Patton Boggs (US) LLP
Jan
31
2023
The FDA Gets Blunt: “New Regulatory Pathway for CBD is Needed” Dinsmore & Shohl LLP
Jan
31
2023
Old North State Report – Jan. 30, 2023 Nelson Mullins
Jan
31
2023
FDA Issues Final and Draft Guidance Documents Regarding Food Allergen Labeling Epstein Becker & Green, P.C.
Jan
31
2023
FDA Issues Procedural Notice on Front-of-Package Labeling Research Keller and Heckman LLP
Jan
31
2023
Are Medical Diagnostic Methods Patent Ineligible by Convention?: CareDx, Inc. v. Natera, Inc. and Eurofins Viracor, Inc. K&L Gates LLP
Jan
31
2023
This Week in 340B: January 24 – 30, 2023 McDermott Will & Emery
Jan
30
2023
FDA Announces Important Shift in CBD Products Regulation Bradley Arant Boult Cummings LLP
Jan
30
2023
FDA Finalizes Guidance to Prevent Unsafe Contamination of Animal Feed from Drug Carryover Keller and Heckman LLP
Jan
29
2023
Beltway Buzz, January 27, 2023 Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jan
27
2023
FDA Concludes that New Regulatory Frameworks for Foods and Supplements Containing Cannabidiol are Needed, Will Work with Congress Keller and Heckman LLP
Jan
26
2023
FDA Passes New Cannabis Guidance for Clinical Research Beveridge & Diamond PC
Jan
26
2023
2023 Federal Forecast – Agriculture ArentFox Schiff LLP
Jan
26
2023
Do the Products You Sell Contain PFAS? Hunton Andrews Kurth
Jan
26
2023
Cannabis: Goin’ to Carolina in My Mind Bradley Arant Boult Cummings LLP
Jan
25
2023
Further Restrictions on Food and Drink Labeling OLIVARES
Jan
25
2023
Modernization of Cosmetics Regulation Act of 2022: What You Need to Know
Jan
25
2023
FDA Finalizes Cannabis Guidance Focusing on Clinical Research and Quality Considerations Nelson Mullins
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters